p53 and Bcl-2 expression in pneumoconiosis-related pre-cancerous lesions and lung cancers: Frequent and preferential p53 expression in pneumoconiotic bronchiolar dysplasias

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 504-511

  Katabami, M ^a,e   Dosaka Akita, H ^b   Honma, K ^c   Kimura, K ^a   Fujino, M ^b   Uchida, Y ^a   Mikami, H ^a   Ohsaki, Y ^a   Kawakami, Y ^b   Kikuchi, K ^d  

^a Iwamizawa Rosai Hospital   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Iwamizawa Rosai Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ARTICLE; BRONCHIOLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG DYSPLASIA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PNEUMOCONIOSIS; PRECANCER; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

BRONCHI; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; PNEUMOCONIOSIS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-BCL-2; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032498506     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<504::AID-IJC3>3.0.CO;2-X     Document Type: Article

References (41)

1. AUERBACH, O., Pathogenesis of lung cancer. Cancer, 7, 11-21 (1962).
2. BEN EZRA, J.M., KORNSTEIN, M.J., GRIMES, M.M. and KRYSTAL, G., all cell carcinomas of the lung express the bcl-2 protein. Amer. J. Pathol., 145, 1036-1040 (1994).
3. CAGLE, P.T., FRAIRE, A.E., GREENBERG, S.D., COX, A. and BROWN, R.W., Potential utility of p53 immunopositivity in differentiation of adenocarcinomas from reactive epithelial atypias of the lung. Hum. Pathol., 27, 1198-1203 (1996).
4. CARTA, P., COCCO, P.L. and PICCHIRI, G., Lung cancer mortality and airways obstruction among metal miners exposed to silica and low levels of radon daughters. Amer. J. ind. Med., 25, 489-506 (1994).
5. CHECKOWAY, H., HEYER, N.J., DEMERS, P.A. and BRESLOW, N.E., Mortality among workers in the diatomaceous earth industry. Brit. J. ind. Med., 50, 586-597 (1993).
6. CHIYOTANI, K., SAITO, K., OKUBO, T. and TAKAHASHI, K., Lung cancer risk among pneumoconiosis patients in Japan, with special reference to silicotics. In: L. Simonato, A.C. Fletcher, R. Saracci and T.L. Thomas (eds.), Occupational exposure to silica and cancer risk, pp. 95-104. International Agency for Research on Cancer, Lyon (1990).
7. FONTANINI, F., VIGNATI, S., BIGINI, D., MUSSI, A., LUCCHI, M., ANGELETTI, C.A., BASOLO, F. and BEVILACQUA, G., Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Brit. J. Cancer, 71, 1003-1007 (1995).
8. FUJINO, M., DOSAKA-AKITA, H., HARADA, M., HIROUMI, H., KINOSHITA, I., AKIE, K. and KAWAKAMI, Y. Prognostic significance of p53 and ras p21 expression in non-small cell lung cancer, Cancer, 76, 2457-2463 (1995).
9. FUJISAWA, Y. and KIKUCHI, K., Clinicopathological studies on silicosis. Sapporo med. J., 44, 252-274 (1975).
10. GREEN, F.H.Y. and CHURG, A., Diseases due to nonasbestos silicates. In: F.H.Y Green and A. Churg (eds.), Pathology of occupational lung disease, pp. 177-211, Igaku-Shoin. New York (1988).
11. GREHNBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878 (1994).
12. HNIZDO, E., MURRAY, J. and KLEMPMAN, S., Lung cancer in relation to exposure to silica dust, silicosis and uranium production in South African gold miners. Thorax, 52, 271-275 (1997).
13. HOCKENBERY, D.M., NUNEZ, G., MlLLIMAN, C., SCHREBER, R.D. and KORSMEYER, S.J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348,33-4-336 (1990).
14. HOLLSTEIN, M., SlDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutation in human cancers. Science, 253, 49-53 (1991).
15. HONMA, K. and CHIYOTANI, K., Diffuse interstitial fibrosis in nonasbestos pneumoconiosis - a pathological study. Respiration, 60, 120-126 (1993).
16. HONMA, K., CHIYOTANI, K. and KIMURA, K. Silicosis. mixed dust pneumoconiosis and lung cancer. Amer. J. ind. Med. 32, 595-599 (1997).
17. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, Silica and some silicates, IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 42, pp. 39-143. IARC. Lyon (1987).
18. INTERNATIONAL LABOUR OFFICE. Guidelines for the use of ILO international classification of radiographs of pneumoconiosis, Occupational Safety and Health Series 22, ILO, Geneva (1980).
19. KASTAN, M.B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B and CRAIG, R.W., Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311 (1991).
20. KENNEDY, M.M., LAMB, D., KING, G. and KERR, K.M., Cell proliferation, cell loss and expression of bcl-2 and p53 in human pulmonary neoplasms. Brit. J. Cancer, 75, 545-547 (1997).
21. LU, P.J., LU, Q.L., RUGHETTI, A. and TAYLOR-PAPADIMITRIOU, J., bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis, of human mammary epithelial cells. J. Cell Biol., 129, 1363-1378 (1995).
22. LU, Q., ABEL, P., FOSTER, C.S. and LALANI, E., bcl-2: role in epithelial differentiation and oncogenesis. Hum. Pathol., 27, 102-110 (1996).
23. MEIJERS, J.M., SWAEN, G.M., VOLOVICS, A., SLANGEN, J.J. and VAN VLIET, K., Silica exposure and lung cancer in ceramic workers: a case-control study. Int. J. Epidemiol., 19, 19-25 (1990).
24. MIYASHITA, T., HARIGAI, M., HANADA, M. and REED, J.C., Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res., 54, 3131-3135 (1994).
25. NlSHIO, M., KOSHIKAWA, T., KUROISHI, T., SUYAMA, M., UCHIDA, K., TAKAGI, Y., WASHIMI, O., SUGIURA, T., ARIYOSHI, Y., TAKAHASHI, T., UEDA, R. and TAKAHASHI, T., Prognostic significance of abnormal p53 accumulation in primary resected non-small-cell lung cancers. J. clin. Oncol., 14, 497-502 (1996).
26. OHSAKI, Y., TOYOSHIMA, E., FUJIUCHI, S., MATSUI, H., HIRATA, S., MIYOKAWA, N., KUBO, Y. and KIKUCHI, K., bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time. Clin. Cancer Res., 2, 915-920 (1996).
27. PEZZELLA, F., TURLEY, H., KUZU, I., TUNGEKAR, M.F., DUNNHILL, M.S. and PIERCE, C.B., bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med., 329, 690-694 (1993).
28. RYAN, J.J., PROCHOWNIK, E., GOTTLIEB, C.A., APEL, I.J., MERINO, R., NUNEZ, G. and CLARKE, M.F., c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc. nat. Acad. Sci. (Wash.), 91, 5878-5882 (1994).
29. SACCOMANNO, G., ARCHER, V.E., AURBACH, O., SAUNDERS, R.P. and BRENNAN, L.M., Development of carcinoma of the lung as reflected in exfoliated cells. Cancer, 33, 256-270 (1974).
30. SAFFIOTI, U., Lung cancer induction by crystalline silica. In: R. D'Amato,T. Slaga, W. Farland and C. Henry (eds.), Relevance of animal studies to the evaluation oj human cancer risk, pp. 51-69. Wiley-Liss. New York (1992).
31. SIMOSATO, Y. and MILLER, R.R., Benign epithelial lesions. In: Y. Simosato and R.R. Miller (eds.), Biopsy interpretation of the lung, pp. 252-268. Raven, New York (1995).
32. SOUSSI, T., LEGROS, Y., LUBIN, R., ORY, K. and SCHLICHTHOLZ, B., Multifactorial analysis of p53 alteration in human cancer: a review. Int. J. Cancer, 57, 1-9 (1994).
33. SOZZI, G., MIOZZO, M., DONGHI, R., PILOTTI, S., CARIANI, C.T., PASTORINO, U., DELLA PORTA, G. and PIEROTTI, M.A., Deletion of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res., 52, 6079-6082 (1992).
34. STARZYNSKI, Z., MAREK, K., KUJAWSKA, A. and SZYMCZAK, W., Mortality among different occupational groups of workers with pneumoconiosis: results from a register-based cohort study. Amer. J. ind. Med., 30, 718-725 (1996).
35. STEENLAND, K., LOOMIS, D., SHY, C. and SIMONSEN, N., Review of occupational lung carcinogens. Amer. J. ind. Med., 29, 474-490 (1996).
36. SUNDARESAN, V., GANLY, P., HASLETON, P., RUDD, R., SlNHA, G., BLEEHEN, N.M. and RABBITTS, P., p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene, 7, 1989-1997 (1992).
37. TSUJIMOTO, Y. and CROCE, C.M., Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. nat. Acad. Sci. (Wash.), 83, 5214-5218 (1986).
38. WALKER, C., ROBERTSON, L., MYSKOW, M. and DIXON, G., Expression of the bcl-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Brit. J. Cancer, 72, 164-169 (1995).
39. WANG, Z., DONG, D., LIANG, X., QU, G., WU, J. and XU, X., Cancer mortality among silicotics in China's metallurgical industry. Int. J. Epidemiol., 25, 913-917 (1996).
40. WORLD HEALTH ORGANIZATION, Histological typing of lung tumors, 2nd ed., pp. 25-26. WHO, Geneva (1981).
41. YONISH-ROUACH, E., RESNITZKY, D., LOTEM, J., SACHS, L., KIMCHI, A. and OREN, M., Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352, 345-347 (1991).